Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
American Heart Journal|September 7, 2016
Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trialArthur E Stillman, Constantine Gatsonis, João A C Lima, et al.JAMA Oncology|May 15, 2020
Clinical Application of Computational Methods in Precision Oncology: A ReviewOrestis A Panagiotou, Lori Hoffman Högg, Hedvig Hricak, et al.Journal of Surgical Oncology|September 24, 2005
Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trialConstance D Lehman, Jeffrey D Blume, David Thickman, et al.Radiology|March 29, 2008
Accuracy of soft-copy digital mammography versus that of screen-film mammography according to digital manufacturer: ACRIN DMIST retrospective multireader studyR Edward Hendrick, Elodia B Cole, Etta D Pisano, et al.JAMA Neurology|November 30, 2020
Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive ImpairmentLeonardo Iaccarino, Renaud La Joie, Orit H Lesman-Segev, et al.Cancer|September 22, 2011
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysisKathryn P Lowry, Janie M Lee, Chung Y Kong, et al.Radiology|April 1, 2009
Comparison of soft-copy and hard-copy reading for full-field digital mammographyRobert M Nishikawa, Suddhasatta Acharyya, Constantine Gatsonis, et al.Radiology|August 13, 2015
Metrology Standards for Quantitative Imaging BiomarkersDaniel C Sullivan, Nancy A Obuchowski, Larry G Kessler, et al.JAMA|April 3, 2019
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or DementiaGil D Rabinovici, Constantine Gatsonis, Charles Apgar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2012
ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expressionAnnick D Van den Abbeele, Constantine Gatsonis, Daniel J de Vries, et al.Pageof 11